Macrury, Sandra

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3,163

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 638

The use of technology to promote physical activity in Type 2 diabetes management: a systematic review

Connelly, J., Kirk, A., Masthoff, J., & MacRury, S. (2013) · Diabetic Medicine

Mobile Health and mHealth ApplicationsPhysical Activity and Health

Cited by 169

Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications

Jeyam, A., Colhoun, H., McGurnaghan, S., Blackbourn, L., McDonald, T. J., Palmer, C. N. A., McKnight, J. A., Strachan, M. W. J., Patrick, A. W., Chalmers, J., et al. (2021) · Diabetes Care

Diabetes Management and ResearchDiabetes and associated disorders

Cited by 118

Performance of a new meter designed for assisted monitoring of blood glucose and point-of-care testing

MacRury, S., Srinivasan, A., & Mahoney, J. J. (2013) · Journal of Diabetes Science and Technology

Diabetes Management and ResearchClinical Laboratory Practices and Quality Control

Cited by 7